isonea rapidly approaches commercialisation

http://www.proactiveinvestors.com/companies/news/25053/isonea-rapidly-approaches-commercialisation-targets-us16-billion-asthma-market-25053.html

"Another strategic advantage of the partnership is that it offers iSonea exposure to Qualcomm’s highly respected venture capital arm, Qualcomm Ventures."

"This new partnership with Qualcomm also, importantly, provides confidence to other strategic partners iSonea is in initial discussions with as to the credibility of the company and the quality of its technology."

ISN has never been in a better position. A matter of time.

Trading Halt anyone?